In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that, amidst a recent downturn in the company’s stock, Lars Fruergaard Jørgensen would soon be stepping down as its top executive and the board would […]